Comparison of outcomes and costs of extracorporeal blood purification therapies in critically ill COVID-19 patients.
Soroush DianatySanaz KhodadadiRojina AlimoghaddamAbasat MirzaeiPublished in: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy (2022)
Plasmapheresis and hemoperfusion do not differ significantly in patient survival, ICU costs and side-effects with a higher incidence of hypocalcemia and thrombocytopenia compared witcontrols.